THE ROLE OF ANTINEUTROPHIL CYTOPLASM ANTIBODIES, ANTICARDIOLIPIN ANTIBODIES, VONWILLEBRAND-FACTOR ANTIGEN, AND FIBRONECTIN FOR THE DIAGNOSIS OF SYSTEMIC VASCULITIS

被引:0
|
作者
BLEIL, L
MANGER, B
WINKLER, TH
HERRMAN, M
BURMESTER, GR
KRAPF, FE
KALDEN, JR
机构
关键词
SYSTEMIC VASCULITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; FIBRONECTIN; VONWILLEBRAND FACTOR ANTIGEN;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Autoantibodies directed against cytoplasmic components of neutrophil granulocytes and monocytes (c-ANCA) are a disease specific marker for Wegener's granulomatosis (WG). Autoantibodies against cardiolipin (aCl) are specific for a subgroup of autoimmune disorders, which can also be associated with systemic vasculitis. Fibronectin (Fn) and von Willebrand factor antigen (vWfAg) are produced by blood vessel endothelial cells in response to injury. We tested sera of 61 patients with various types of systemic vasculitides, sera of 13 patients with retinal vasculitis, and sera of 199 patients with rheumatic diseases for c-ANCA, aCl, Fn, and vWfAg. c-ANCA was positive in 14/17 patients with WG, and 2/4 with polyarteritis nodosa (PAN). No serum from healthy donors or patients with other vasculitic or rheumatic diseases was positive for c-ANCA. Moreover, we found aCl, Fn, and vWfAg significantly elevated in almost all patients with vasculitic syndromes. Therefore, we consider c-ANCA a marker, specific for the diagnosis of WG or PAN, whereas aCl, Fn, and vWfAg are nonspecific but sensitive markers of vascular damage.
引用
收藏
页码:1199 / 1206
页数:8
相关论文
共 15 条
  • [1] VENOSTASIS, SUBCLINICAL VASCULITIS AND VONWILLEBRAND-FACTOR ANTIGEN
    BLANN, AD
    WAINWRIGHT, AC
    SHEERAN, TP
    EMERY, P
    BRITISH JOURNAL OF RHEUMATOLOGY, 1991, 30 (05): : 373 - 375
  • [2] Production of antineutrophil cytoplasm antibodies derived from circulating B cells in patients with systemic vasculitis
    Clayton, AR
    Savage, COS
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2003, 132 (01) : 174 - 179
  • [3] ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES - TOOLS FOR DIAGNOSIS AND FOLLOW-UP IN SYSTEMIC VASCULITIS
    STEGEMAN, CA
    TERVAERT, JWC
    KALLENBERG, CGM
    ANNALES DE MEDECINE INTERNE, 1994, 145 (08): : 523 - 532
  • [4] ANTINEUTROPHIL CYTOPLASM ANTIBODIES IN PATIENTS WITH ACR CRITERIA FOR POLYARTERITIS-NODOSA - HELP FOR SYSTEMIC VASCULITIS CLASSIFICATION
    BARANGER, TAR
    AUDRAIN, MAP
    TESTA, A
    BESNIER, D
    GUILLEVIN, L
    ESNAULT, VLM
    AUTOIMMUNITY, 1995, 20 (01) : 33 - 37
  • [5] ELISA is the superior method for detecting antineutrophil cytoplasmic antibodies in the diagnosis of systemic necrotising vasculitis
    Harris, A
    Chang, G
    Vadas, M
    Gillis, D
    JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (09) : 670 - 676
  • [6] Endothelial cells, antineutrophil cytoplasmic antibodies, and cytokines in the pathogenesis of systemic vasculitis.
    Cid M.C.
    Segarra M.
    García-Martínez A.
    Hernández-Rodríguez J.
    Current Rheumatology Reports, 2004, 6 (3) : 184 - 194
  • [7] Antineutrophil cytoplasmic antibodies (ANCA) - their role in pathogenesis, diagnosis, and treatment monitoring of ANCA-associated vasculitis
    Fijolek, Justyna
    Wiatr, Elzbieta
    CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY, 2020, 45 (02) : 218 - 227
  • [8] Mycophenolate mofetil in anti-neutrophil cytoplasm antibodies-associated systemic vasculitis
    Koukoulaki, M
    Jayne, DRW
    NEPHRON CLINICAL PRACTICE, 2006, 102 (3-4): : C100 - C107
  • [9] ANCA (antineutrophil cytoplasmic antibodies): contribution to our understanding of the pathogenic mechanisms in systemic vasculitis.
    De Bandt, M
    ANNALES DE MEDECINE INTERNE, 1997, 148 (08): : 542 - 562
  • [10] Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: Prevalence, antigen specificity, and clinical associations
    Manolova I.
    Dancheva M.
    Halacheva K.
    Rheumatology International, 2001, 20 (5) : 197 - 204